The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An … V Debien, E Agostinetto, M Bruzzone, M Ceppi, D Martins-Branco, ... Clinical Breast Cancer 24 (5), 421-430. e3, 2024 | | 2024 |
Impact of Hormone Receptor Status and Tumor Subtypes of Breast Cancer in Young BRCA Carriers L Arecco, M Bruzzone, R Bas, HJ Kim, A Di Meglio, R Bernstein-Molho, ... Annals of Oncology, 2024 | | 2024 |
Impact of Hormone Receptor Status and Tumor Subtypes on Clinical Behavior and Outcomes of Breast Cancer in Young BRCA Carriers L Arecco, M Bruzzone, R Bas, HJ Kim, A Di Meglio, R Bernstein-Molho, ... | | 2024 |
DNA damaging effects of occupational exposure to glass fibres. Response to Madl and Keeton paper M Ceppi, B Smolkova, V Buocikova, E Rundén-Pran, N El Yamani, ... Mutation research. Genetic toxicology and environmental mutagenesis 896, 503770, 2024 | | 2024 |
Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study S Curti, M Gallo, D Ferrante, F Bella, L Boschetti, V Casotto, M Ceppi, ... La Medicina del Lavoro 115 (2), 2024 | | 2024 |
Cause specific mortality in an Italian pool of asbestos workers cohorts D Ferrante, A Angelini, F Barbiero, F Barbone, L Bauleo, A Binazzi, ... American Journal of Industrial Medicine 67 (1), 31-43, 2024 | 1 | 2024 |
Interleukin-2 gene methylation levels and interleukin-2 levels associated with environmental exposure as risk biomarkers for preterm birth A Fučić, J Knežević, J Krasić, D Polančec, N Sinčić, NS Dessardo, ... Croatian Medical Journal 64 (5), 320, 2023 | 1 | 2023 |
186P Pooled efficacy and safety data of alectinib (A) vs. crizotinib (C) from the randomized phase III ALEX and J-ALEX trials M Tagliamento, M Bruzzone, M Ceppi, C Genova, FG Dall'Olio, M Aldea, ... Annals of Oncology 34, S255-S256, 2023 | | 2023 |
Effect of Air Pollution on the Basal DNA Damage of Mother–Newborn Couples of México City M Valverde, A Granados, M Milić, M Ceppi, L Sollano, S Bonassi, E Rojas Toxics 11 (9), 766, 2023 | 2 | 2023 |
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis C Molinelli, F Jacobs, E Agostinetto, G Nader-Marta, M Ceppi, ... ESMO open 8 (4), 101592, 2023 | 19 | 2023 |
Activity and safety of first-line treatments for advanced melanoma: a network meta-analysis A Boutros, ET Tanda, E Croce, F Catalano, M Ceppi, M Bruzzone, ... European Journal of Cancer 188, 64-79, 2023 | 8 | 2023 |
A meta-analysis of endoscopic stenting versus surgical treatment for malignant gastric outlet obstruction L Del Nero, AD Sheijani, A De Ceglie, M Bruzzone, M Ceppi, RA Filiberti, ... World Journal of Surgery 47 (6), 1519-1529, 2023 | 2 | 2023 |
228P The impact of initial tumor response to docetaxel, trastuzumab, and pertuzumab on survival outcomes of patients with HER2+ metastatic breast cancer: An exploratory … V Debien, E Agostinetto, M Bruzzone, M Ceppi, C Molinelli, DM Branco, ... ESMO Open 8 (1), 2023 | | 2023 |
Traffic-Related Air Pollution and Ground-Level Ozone Associated Global DNA Hypomethylation and Bulky DNA Adduct Formation A Munnia, V Bollati, V Russo, L Ferrari, M Ceppi, M Bruzzone, S Dugheri, ... International Journal of Molecular Sciences 24 (3), 2041, 2023 | 1 | 2023 |
Genotoxic effects of occupational exposure to glass fibres-A human biomonitoring study M Ceppi, B Smolkova, M Staruchova, A Kazimirova, M Barancokova, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 885, 503572, 2023 | 4 | 2023 |
Impact of anti-HER2 therapy alone and with weekly paclitaxel on the ovarian reserve of young women with HER2-positive breast cancer M Lambertini, M Ceppi, RA Anderson, DA Cameron, M Bruzzone, ... Journal of the National Comprehensive Cancer Network 21 (1), 33-41. e16, 2023 | 8 | 2023 |
Improved isolation of carbapenem-resistant Enterobacterales on selective-differential media extending the incubation time: an approach to strengthen the antimicrobial … G Piatti, AM Schito, A Vitale, M Bruzzone, M Ceppi Journal of Hospital Infection 129, 102-109, 2022 | 2 | 2022 |
Seminal plasma N-glycome as a new biomarker of environmental exposure associated with semen quality T Marić, I Wójcik, AK Bojanac, A Matijević, M Ceppi, M Bruzzone, ... Reproductive toxicology 113, 96-102, 2022 | 2 | 2022 |
Artificial intelligence predictive models of response to cytotoxic chemotherapy alone or combined to targeted therapy for metastatic colorectal cancer patients: a systematic … V Russo, E Lallo, A Munnia, M Spedicato, L Messerini, R D’Aurizio, ... Cancers 14 (16), 4012, 2022 | 17 | 2022 |
Comment on “Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta‑analysis” F Poggio, M Ceppi, P Fregatti, M Lambertini, M Tagliamento Breast Cancer Research and Treatment 194 (3), 709-710, 2022 | | 2022 |